EFFICACY PROFILE OF THE CYD-TDV DENGUE VACCINE: BAYESIAN SURVIVAL ANALYSIS OF INDIVIDUAL PHASE III TRIAL DATA

被引：0
|
作者：
Laydon, Daniel [1 ]
Dorigatti, Ilaria [1 ]
Small, Robert [2 ]
Jackson, Nick [3 ]
Coudeville, Laurent [4 ]
Ferguson, Neil [1 ]
机构：
[1] Imperial Coll, London, England
[2] Sanofi Pasteur, Orlando, FL USA
[3] Sanofi Pasteur, Marcy Letoile, France
[4] Sanofi Pasteur, Lyon, France
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2018年 / 99卷 / 04期
基金：
比尔及梅琳达.盖茨基金会;
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
769
引用
收藏
页码：242 / 242
页数：1
相关论文
共 50 条
  • [1] Efficacy profile of the CYD-TDV dengue vaccine revealed by Bayesian survival analysis of individual-level phase III data
    Laydon, Daniel J.
    Dorigatti, Ilaria
    Hinsley, Wes R.
    Nedjati-Gilani, Gemma
    Coudeville, Laurent
    Ferguson, Neil M.
    ELIFE, 2021, 10
  • [2] VIRAL GENETIC DIVERSITY AND PROTECTIVE EFFICACY OF A CYD-TDV TETRAVALENT DENGUE VACCINE IN A PHASE 3 TRIAL IN ASIA
    Magaret, Craig A.
    Juraska, Michal
    Shao, Jason
    Carpp, Lindsay N.
    Fiore-Gartland, Andrew J.
    Benkeser, David
    Girerd-Chambaz, Yves
    Langevin, Edith
    Frago, Carina
    Guy, Bruno
    Edlefsen, Paul T.
    Gilbert, Peter B.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 194 - 194
  • [3] CYD-TDV dengue vaccine: systematic review and meta-analysis of efficacy, immunogenicity and safety
    Godoi, Isabella Piassi
    Pires Lemos, Livia Lovato
    de Araujo, Vania Eloisa
    Bonoto, Braulio Cesar
    Godman, Brian
    Guerra Junior, Augusto Afonso
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2017, 6 (02) : 165 - 180
  • [4] Refined efficacy estimates of the Sanofi Pasteur dengue vaccine CYD-TDV using machine learning
    I. Dorigatti
    C. A. Donnelly
    D. J. Laydon
    R. Small
    N. Jackson
    L. Coudeville
    N. M. Ferguson
    Nature Communications, 9
  • [5] Refined efficacy estimates of the Sanofi Pasteur dengue vaccine CYD-TDV using machine learning
    Dorigatti, I.
    Donnelly, C. A.
    Laydon, D. J.
    Small, R.
    Jackson, N.
    Coudeville, L.
    Ferguson, N. M.
    NATURE COMMUNICATIONS, 2018, 9
  • [6] IMMUNOGENICITY OF THE CYD TETRAVALENT DENGUE VACCINE (CYD-TDV) USING A COMPRESSED SCHEDULE: RANDOMIZED PHASE II STUDY IN US ADULTS
    Kirstein, Judith
    Douglas, William
    Thakur, Manoj
    Boaz, Mark
    Papa, Thomas
    Skipetrova, Anna
    Plennevaux, Eric
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 433 - 433
  • [7] INTEGRATED IMMUNOGENICITY ANALYSIS OF A TETRAVALENT DENGUE VACCINE (CYD-TDV) UP TO 4 YEARS AFTER VACCINATION
    Vigne, Claire
    Dupuy, Martin
    Richetin-Guilluy, Aline
    Guy, Bruno
    Jackson, Nicholas
    Bonaparte, Matthew
    Hu, Branda
    Saville, Melanie
    Chansinghakul, Danaya
    Noriega, Fernando
    Plennevaux, Eric
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 434 - 434
  • [8] Accuracy, efficacy and safety of dengue CYD-TDV pre-vaccination screening with 5 existing IgG serotests: Retrospective analysis of phase III trials
    Diazgranados, C.
    Bonaparte, M.
    Lustig, Y.
    Forrat, R.
    Dayan, G.
    Wang, H.
    Zhu, M.
    Hodge, S.
    Schwartz, E.
    Ataman-Onal, Y.
    Savarino, S.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 101 : 479 - 480
  • [9] Clinical efficacy, Safety, and immunogenicity of a Live Attenuated Tetravalent Dengue vaccine (CYD-TDv) in Children: A Systematic Review with Meta-analysis
    Malisheni, Moffat
    Khaiboullina, Svetlana F.
    Rizvanov, Albert A.
    Takah, Noah
    Murewanhema, Grant
    Bates, Matthew
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [10] 3 years of post-licensure safety data on a live attenuated tetravalent dengue vaccine (CYD-TDV)
    Rojas, Andrey
    Haney, Owen
    Marcelon, Lydie
    Khromava, Alena
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 390 - 391
12345